Department of Pediatrics, University of Groningen, University Medical Center Groningen, 9700 RB, Groningen, The Netherlands.
Endocrinology. 2012 Aug;153(8):3713-23. doi: 10.1210/en.2011-1891. Epub 2012 May 31.
Synthetic glucocorticoids such as prednisolone have potent antiinflammatory actions. Unfortunately, these drugs induce severe adverse effects in patients, many of which resemble features of the metabolic syndrome, such as insulin resistance. In this study, we investigated whether adverse effects of prednisolone on glucose homeostasis are aggravated in mice with compromised insulin sensitivity due to a high-fat diet by applying various methods to analyze changes in insulin sensitivity in mice. C57BL/6J mice were fed a high-fat diet for 6 wk and treated with either prednisolone (10 mg/kg · d) or vehicle for the last 7 d. Insulin sensitivity and blood glucose kinetics were analyzed with state-of-the-art stable isotope procedures in different experimental conditions. Prednisolone treatment aggravated fasting hyperglycemia and hyperinsulinemia caused by high-fat feeding, resulting in a higher homeostatic assessment model of insulin resistance. In addition, prednisolone-treated high-fat diet-fed mice appeared less insulin sensitive by detailed analysis of basal glucose kinetics. Remarkably, using hyperinsulinemic-euglycemic or hyperglycemic clamp techniques, neither hepatic nor peripheral insulin resistance was worsened in the group that was treated with prednisolone. Yet analysis of hepatic glucose metabolism revealed that prednisolone did alter glycogen balance by reducing glycogen synthase flux under hyperinsulinemic as well as hyperglycemic conditions. In addition to elevated insulin levels, prednisolone-treated mice showed a major rise in plasma leptin and fibroblast growth factor 21 levels. Our data indicate that prednisolone-induced adverse effects on glucose metabolism in high-fat diet-fed mice do not reflect impaired insulin sensitivity but may be caused by other changes in the hormonal regulatory network controlling glucose metabolism such as fibroblast growth factor 21 and leptin.
合成糖皮质激素如泼尼松龙具有很强的抗炎作用。不幸的是,这些药物会在患者中引起严重的不良反应,其中许多与代谢综合征的特征相似,如胰岛素抵抗。在这项研究中,我们通过应用各种方法来分析小鼠胰岛素敏感性的变化,研究了由于高脂肪饮食导致胰岛素敏感性受损的小鼠中泼尼松龙对葡萄糖稳态的不良影响是否会加重。将 C57BL/6J 小鼠用高脂肪饮食喂养 6 周,并在最后 7 天用泼尼松龙(10mg/kg·d)或载体处理。用最新的稳定同位素方法在不同的实验条件下分析胰岛素敏感性和血糖动力学。泼尼松龙治疗加重了高脂肪饮食引起的空腹高血糖和高胰岛素血症,导致稳态评估模型的胰岛素抵抗更高。此外,通过对基础血糖动力学的详细分析,泼尼松龙治疗的高脂肪饮食喂养小鼠似乎对胰岛素的敏感性降低。值得注意的是,使用高胰岛素-正常血糖或高血糖钳夹技术,泼尼松龙治疗组的肝和外周胰岛素抵抗并没有恶化。然而,对肝葡萄糖代谢的分析表明,泼尼松龙通过在高胰岛素和高血糖条件下降低糖原合酶通量来改变糖原平衡。除了胰岛素水平升高外,泼尼松龙治疗的小鼠还表现出血浆瘦素和成纤维细胞生长因子 21 水平的显著升高。我们的数据表明,泼尼松龙在高脂肪饮食喂养小鼠中引起的葡萄糖代谢不良影响并不反映胰岛素敏感性受损,而可能是由控制葡萄糖代谢的激素调节网络的其他变化引起的,如成纤维细胞生长因子 21 和瘦素。